Literature DB >> 26590421

Hippocampal Dopamine/DRD1 Signaling Dependent on the Ghrelin Receptor.

Andras Kern1, Maria Mavrikaki2, Celine Ullrich2, Rosie Albarran-Zeckler2, Alicia Faruzzi Brantley3, Roy G Smith4.   

Abstract

The ghrelin receptor (GHSR1a) and dopamine receptor-1 (DRD1) are coexpressed in hippocampal neurons, yet ghrelin is undetectable in the hippocampus; therefore, we sought a function for apo-GHSR1a. Real-time single-molecule analysis on hippocampal neurons revealed dimerization between apo-GHSR1a and DRD1 that is enhanced by DRD1 agonism. In addition, proximity measurements support formation of preassembled apo-GHSR1a:DRD1:Gαq heteromeric complexes in hippocampal neurons. Activation by a DRD1 agonist produced non-canonical signal transduction via Gαq-PLC-IP3-Ca(2+) at the expense of canonical DRD1 Gαs cAMP signaling to result in CaMKII activation, glutamate receptor exocytosis, synaptic reorganization, and expression of early markers of hippocampal synaptic plasticity. Remarkably, this pathway is blocked by genetic or pharmacological inactivation of GHSR1a. In mice, GHSR1a inactivation inhibits DRD1-mediated hippocampal behavior and memory. Our findings identify a previously unrecognized mechanism essential for DRD1 initiation of hippocampal synaptic plasticity that is dependent on GHSR1a, and independent of cAMP signaling.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26590421      PMCID: PMC4937825          DOI: 10.1016/j.cell.2015.10.062

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  42 in total

1.  T-maze alternation in the rodent.

Authors:  Robert M J Deacon; J Nicholas P Rawlins
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Heterodimerization with Its splice variant blocks the ghrelin receptor 1a in a non-signaling conformation: a study with a purified heterodimer assembled into lipid discs.

Authors:  Sophie Mary; Jean-Alain Fehrentz; Marjorie Damian; Gérald Gaibelet; Hélène Orcel; Pascal Verdié; Bernard Mouillac; Jean Martinez; Jacky Marie; Jean-Louis Banères
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

Review 3.  Single-molecule imaging revealed dynamic GPCR dimerization.

Authors:  Rinshi S Kasai; Akihiro Kusumi
Journal:  Curr Opin Cell Biol       Date:  2013-12-17       Impact factor: 8.382

4.  Ghrelin agonists impact on Fos protein expression in brain areas related to food intake regulation in male C57BL/6 mice.

Authors:  Z Pirnik; J Bundziková; M Holubová; M Pýchová; J A Fehrentz; J Martinez; B Zelezná; L Maletínská; A Kiss
Journal:  Neurochem Int       Date:  2011-08-06       Impact factor: 3.921

5.  D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons.

Authors:  Nelson Lezcano; Clare Bergson
Journal:  J Neurophysiol       Date:  2002-04       Impact factor: 2.714

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Characterization of a novel ghrelin cell reporter mouse.

Authors:  Ichiro Sakata; Yoshihide Nakano; Sherri Osborne-Lawrence; Sherry A Rovinsky; Charlotte E Lee; Mario Perello; Jason G Anderson; Roberto Coppari; Guanghua Xiao; Bradford B Lowell; Joel K Elmquist; Jeffrey M Zigman
Journal:  Regul Pept       Date:  2009-04-08

8.  Ghrelin acts as an interface between physiological state and phasic dopamine signaling.

Authors:  Jackson J Cone; James E McCutcheon; Mitchell F Roitman
Journal:  J Neurosci       Date:  2014-04-02       Impact factor: 6.167

9.  Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons.

Authors:  Marie Schaeffer; Fanny Langlet; Chrystel Lafont; François Molino; David J Hodson; Thomas Roux; Laurent Lamarque; Pascal Verdié; Emmanuel Bourrier; Bénédicte Dehouck; Jean-Louis Banères; Jean Martinez; Pierre-François Méry; Jacky Marie; Eric Trinquet; Jean-Alain Fehrentz; Vincent Prévot; Patrice Mollard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

10.  Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition.

Authors:  Jörgen A Engel; Elisabet Jerlhag; Lennart Svensson; Roy G Smith; Emil Egecioglu
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

View more
  34 in total

1.  Growth hormone secretagogue receptor constitutive activity impairs voltage-gated calcium channel-dependent inhibitory neurotransmission in hippocampal neurons.

Authors:  Valentina Martínez Damonte; Silvia Susana Rodríguez; Jesica Raingo
Journal:  J Physiol       Date:  2018-10-14       Impact factor: 5.182

2.  D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease.

Authors:  Irene Sebastianutto; Elise Goyet; Laura Andreoli; Joan Font-Ingles; David Moreno-Delgado; Nathalie Bouquier; Céline Jahannault-Talignani; Enora Moutin; Luisa Di Menna; Natallia Maslava; Jean-Philippe Pin; Laurent Fagni; Ferdinando Nicoletti; Fabrice Ango; M Angela Cenci; Julie Perroy
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 3.  Ghrelin Signaling: GOAT and GHS-R1a Take a LEAP in Complexity.

Authors:  Alfonso Abizaid; James L Hougland
Journal:  Trends Endocrinol Metab       Date:  2019-10-19       Impact factor: 12.015

4.  Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease.

Authors:  Jing Tian; Lan Guo; Shaomei Sui; Christopher Driskill; Aarron Phensy; Qi Wang; Esha Gauba; Jeffrey M Zigman; Russell H Swerdlow; Sven Kroener; Heng Du
Journal:  Sci Transl Med       Date:  2019-08-14       Impact factor: 17.956

5.  MK0677, a Ghrelin Mimetic, Improves Neurogenesis but Fails to Prevent Hippocampal Lesions in a Mouse Model of Alzheimer's Disease Pathology.

Authors:  Jing Tian; Tienju Wang; Qi Wang; Lan Guo; Heng Du
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  Role of Dopaminergic and Cannabinoidergic Receptors on Ghrelin-Induced Hypophagia in 5-Day-Old Broiler Chicken.

Authors:  R Farrokhi; V Babapour; M Zendehdel; A Asghari; H Gilanpour
Journal:  Arch Razi Inst       Date:  2021-10-31

Review 7.  Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.

Authors:  Miguel Pérez de la Mora; Dasiel O Borroto-Escuela; Minerva Crespo-Ramírez; José Del Carmen Rejón-Orantes; Daniel Alejandro Palacios-Lagunas; Magda K Martínez-Mata; Daniela Sánchez-Luna; Emiliano Tesoro-Cruz; Kjell Fuxe
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

Review 8.  The Good, the Bad and the Unknown Aspects of Ghrelin in Stress Coping and Stress-Related Psychiatric Disorders.

Authors:  Eva Maria Fritz; Nicolas Singewald; Dimitri De Bundel
Journal:  Front Synaptic Neurosci       Date:  2020-10-27

9.  A Significant Role of the Truncated Ghrelin Receptor GHS-R1b in Ghrelin-induced Signaling in Neurons.

Authors:  Gemma Navarro; David Aguinaga; Edgar Angelats; Mireia Medrano; Estefanía Moreno; Josefa Mallol; Antonio Cortés; Enric I Canela; Vicent Casadó; Peter J McCormick; Carme Lluís; Sergi Ferré
Journal:  J Biol Chem       Date:  2016-04-25       Impact factor: 5.157

10.  Metabolic Benefit of Chronic Caloric Restriction and Activation of Hypothalamic AGRP/NPY Neurons in Male Mice Is Independent of Ghrelin.

Authors:  Nicole H Rogers; Heidi Walsh; Oscar Alvarez-Garcia; Seongjoon Park; Bruce Gaylinn; Michael O Thorner; Roy G Smith
Journal:  Endocrinology       Date:  2016-01-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.